Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With Immunotherapy
Clinical trial NCT05715229 · RECRUITING
Trial details
- NCT number
- NCT05715229
- Sponsor
- Hackensack Meridian Health
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-29
- Primary completion
- 2027-04-28
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.